Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H7NO3.C4H11NO |
| Molecular Weight | 218.2502 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCO.OC(=O)[C@@H]1CCC(=O)N1
InChI
InChIKey=DAEHWWVKPWBXGD-DFWYDOINSA-N
InChI=1S/C5H7NO3.C4H11NO/c7-4-2-1-3(6-4)5(8)9;1-5(2)3-4-6/h3H,1-2H2,(H,6,7)(H,8,9);6H,3-4H2,1-2H3/t3-;/m0./s1
DEANOL is an inactive component of CERAVE® hydrocortisone anti-itch cream, which is used for temporarily relieve itching associated with minor skin irritations, inflammation, and rashes due to eczema, soaps, detergents, cosmetics, seborrheic dermatitis, psoriasis. DEANOL is also used as a food additive.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % single, topical Highest studied dose Dose: 0.1 % Route: topical Route: single Dose: 0.1 % Sources: Page: p.10 |
healthy Health Status: healthy Sources: Page: p.10 |
|
6000 mg 1 times / day multiple, oral Highest studied dose Dose: 6000 mg, 1 times / day Route: oral Route: multiple Dose: 6000 mg, 1 times / day Sources: Page: p.188 |
unhealthy Health Status: unhealthy Condition: Involuntary movement disorders Sources: Page: p.188 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Improved method for the quality assurance of [C-11]choline. | 2002 Apr |
|
| Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. | 2002 Aug |
|
| [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine. | 2002 Sep |
|
| Reactivity and molecular recognition: amine methylation by an introverted ester. | 2003 Dec 3 |
|
| Water-soluble biodegradable cationic polyphosphazenes for gene delivery. | 2003 May 20 |
|
| C-terminal sequencing method for proteins in polyacrylamide gel by the reaction of acetic anhydride. | 2006 Apr |
|
| Synthesis of isostructural cage complexes of copper with cobalt and nickel for deposition of mixed ceramic oxide materials. | 2006 Dec 25 |
|
| Randomised, placebo-controlled, double-blind, split-face study on the clinical efficacy of Tricutan on skin firmness. | 2007 Nov |
|
| Mannosylated poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymers: synthesis, characterization, and interaction with a bacterial lectin. | 2007 Sep |
|
| Role of the ancillary ligand N,N-dimethylaminoethanol in the sensitization of Eu(III) and Tb(III) luminescence in dimeric beta-diketonates. | 2008 Apr 24 |
|
| Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer. | 2008 Feb |
|
| Experimental and theoretical investigation into the correlation between mass and ion mobility for choline and other ammonium cations in N2. | 2008 Mar 15 |
|
| Strong intramolecular Si-N interactions in the chlorosilanes Cl3-nHnSiOCH2CH2NMe2 (n = 1-3). | 2008 Nov 17 |
|
| Bis[N-(2-hydroxy-ethyl)-N-methyl-glycinato]copper(II). | 2008 Nov 22 |
|
| Mesotherapy - The french connection. | 2010 Jan |
|
| Chloridotris[μ(2)-2-(dimethyl-amino)-ethano-lato]-μ(3)-hydroxido-tri-μ(2)-trifluoro-acetato-tetra-copper(II) tetra-hydro-furan solvate. | 2010 Jun 18 |
|
| In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines. | 2010 Nov |
|
| Novel pathway to synthesize unsymmetrical 2,3,9,10,16,17,23-heptakis(alkoxyl)-24-mono(dimethylaminoalkoxyl)phthalocyanines. | 2010 Oct 4 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60946233
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
23513-72-6
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
SUB13537MIG
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
71777631
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
100000079518
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
236195
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | RxNorm | ||
|
245-706-1
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
V68I8147P0
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY | |||
|
SUB29994
Created by
admin on Sat Dec 16 10:00:07 GMT 2023 , Edited by admin on Sat Dec 16 10:00:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
